Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.07
AMED's Cash to Debt is ranked higher than
58% of the 300 Companies
in the Global Medical Care industry.

( Industry Median: 0.18 vs. AMED: 0.07 )
AMED' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.07

Equity to Asset 0.59
AMED's Equity to Asset is ranked higher than
85% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. AMED: 0.59 )
AMED' s 10-Year Equity to Asset Range
Min: -0.23   Max: 1
Current: 0.59

-0.23
1
Interest Coverage 2.93
AMED's Interest Coverage is ranked higher than
61% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 4.72 vs. AMED: 2.93 )
AMED' s 10-Year Interest Coverage Range
Min: 1.98   Max: 115.64
Current: 2.93

1.98
115.64
F-Score: 4
Z-Score: 3.74
M-Score: -1.92
WACC vs ROIC
9.77%
3.29%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 2.00
AMED's Operating margin (%) is ranked higher than
61% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 9.84 vs. AMED: 2.00 )
AMED' s 10-Year Operating margin (%) Range
Min: -100.58   Max: 15.25
Current: 2

-100.58
15.25
Net-margin (%) 1.06
AMED's Net-margin (%) is ranked higher than
64% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 4.97 vs. AMED: 1.06 )
AMED' s 10-Year Net-margin (%) Range
Min: -97.66   Max: 9.33
Current: 1.06

-97.66
9.33
ROE (%) 3.38
AMED's ROE (%) is ranked higher than
65% of the 289 Companies
in the Global Medical Care industry.

( Industry Median: 10.46 vs. AMED: 3.38 )
AMED' s 10-Year ROE (%) Range
Min: -94.38   Max: 24.6
Current: 3.38

-94.38
24.6
ROA (%) 1.82
AMED's ROA (%) is ranked higher than
66% of the 308 Companies
in the Global Medical Care industry.

( Industry Median: 4.18 vs. AMED: 1.82 )
AMED' s 10-Year ROA (%) Range
Min: -73.91   Max: 14.03
Current: 1.82

-73.91
14.03
ROC (Joel Greenblatt) (%) 16.18
AMED's ROC (Joel Greenblatt) (%) is ranked higher than
73% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 20.06 vs. AMED: 16.18 )
AMED' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -483.95   Max: 387.62
Current: 16.18

-483.95
387.62
Revenue Growth (3Y)(%) -10.50
AMED's Revenue Growth (3Y)(%) is ranked higher than
53% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. AMED: -10.50 )
AMED' s 10-Year Revenue Growth (3Y)(%) Range
Min: -26.1   Max: 35.1
Current: -10.5

-26.1
35.1
» AMED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

AMED Guru Trades in Q1 2014

Jim Simons 144,680 sh (New)
Charles Brandes 165,125 sh (-23.43%)
» More
Q2 2014

AMED Guru Trades in Q2 2014

Jim Simons 338,601 sh (+134.03%)
Charles Brandes 165,290 sh (+0.10%)
» More
Q3 2014

AMED Guru Trades in Q3 2014

Paul Tudor Jones 13,000 sh (New)
Steven Cohen 62,400 sh (New)
Jim Simons 259,501 sh (-23.36%)
Charles Brandes 15,810 sh (-90.43%)
» More
Q4 2014

AMED Guru Trades in Q4 2014

Joel Greenblatt 23,349 sh (New)
Paul Tudor Jones 29,819 sh (+129.38%)
Steven Cohen Sold Out
Charles Brandes Sold Out
Jim Simons 209,801 sh (-19.15%)
» More
» Details

Insider Trades

Latest Guru Trades with AMED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 71.00
AMED's P/E(ttm) is ranked higher than
64% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 43.80 vs. AMED: 71.00 )
AMED' s 10-Year P/E(ttm) Range
Min: 4.64   Max: 80.45
Current: 71

4.64
80.45
Forward P/E 21.79
AMED's Forward P/E is ranked higher than
75% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 28.09 vs. AMED: 21.79 )
N/A
PE(NRI) 70.40
AMED's PE(NRI) is ranked higher than
68% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 44.20 vs. AMED: 70.40 )
AMED' s 10-Year PE(NRI) Range
Min: 4.65   Max: 79.39
Current: 70.4

4.65
79.39
P/B 2.30
AMED's P/B is ranked higher than
79% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 3.14 vs. AMED: 2.30 )
AMED' s 10-Year P/B Range
Min: 0.5   Max: 6.34
Current: 2.3

0.5
6.34
P/S 0.70
AMED's P/S is ranked higher than
84% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 1.75 vs. AMED: 0.70 )
AMED' s 10-Year P/S Range
Min: 0.19   Max: 2.36
Current: 0.7

0.19
2.36
EV-to-EBIT 41.48
AMED's EV-to-EBIT is ranked higher than
68% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 24.39 vs. AMED: 41.48 )
AMED' s 10-Year EV-to-EBIT Range
Min: -859.4   Max: 45.7
Current: 41.48

-859.4
45.7
Current Ratio 0.84
AMED's Current Ratio is ranked higher than
59% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. AMED: 0.84 )
AMED' s 10-Year Current Ratio Range
Min: 0.42   Max: 2.83
Current: 0.84

0.42
2.83
Quick Ratio 0.84
AMED's Quick Ratio is ranked higher than
61% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 1.14 vs. AMED: 0.84 )
AMED' s 10-Year Quick Ratio Range
Min: 0.4   Max: 2.75
Current: 0.84

0.4
2.75
Days Sales Outstanding 30.10
AMED's Days Sales Outstanding is ranked higher than
90% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 50.15 vs. AMED: 30.10 )
AMED' s 10-Year Days Sales Outstanding Range
Min: 27.44   Max: 78.46
Current: 30.1

27.44
78.46

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.70
AMED's Price/Tangible Book is ranked higher than
73% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 19.94 vs. AMED: 5.70 )
AMED' s 10-Year Price/Tangible Book Range
Min: 0.35   Max: 122.85
Current: 5.7

0.35
122.85
Price/DCF (Projected) 0.90
AMED's Price/DCF (Projected) is ranked higher than
95% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 4.30 vs. AMED: 0.90 )
AMED' s 10-Year Price/DCF (Projected) Range
Min: 0.16   Max: 3.91
Current: 0.9

0.16
3.91
Price/Median PS Value 0.90
AMED's Price/Median PS Value is ranked higher than
92% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. AMED: 0.90 )
AMED' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 2.33
Current: 0.9

0.2
2.33
Price/Peter Lynch Fair Value 0.40
AMED's Price/Peter Lynch Fair Value is ranked higher than
79% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMED: 0.40 )
AMED' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.34   Max: 3.24
Current: 0.4

0.34
3.24
Price/Graham Number 4.00
AMED's Price/Graham Number is ranked higher than
78% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMED: 4.00 )
AMED' s 10-Year Price/Graham Number Range
Min: 1.68   Max: 10.66
Current: 4

1.68
10.66
Earnings Yield (Greenblatt) 2.40
AMED's Earnings Yield (Greenblatt) is ranked higher than
61% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 4.50 vs. AMED: 2.40 )
AMED' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.2   Max: 33.7
Current: 2.4

2.2
33.7
Forward Rate of Return (Yacktman) 41.85
AMED's Forward Rate of Return (Yacktman) is ranked higher than
98% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 11.50 vs. AMED: 41.85 )
AMED' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -0.5   Max: 104.4
Current: 41.85

-0.5
104.4

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:ADY.Germany,
Amedisys Inc was originally incorporated in Louisiana in 1982. Its operations were transferred to a Delaware corporation, which was incorporated in 1994; and became a publicly traded company in August of that year. The Company is a provider of low-cost home health services to the chronic, co-morbid, aging American population. The operations involve servicing patients through its two reportable business segments: home health and hospice. The home health segment delivers services in the homes of individuals who may be recovering from an illness, injury or surgery. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Individuals with a terminal illness such as heart disease, pulmonary disease, dementia, Alzheimers, HIV/AIDS or cancer may be eligible for hospice care. The Company operates 41 home health care centers and five hospice care centers with care centers servicing the same markets, sold 19 home health care centers and one hospice care center and closed 10 home health care centers. The Companys operations are regulated by Federal, state and local authorities.
» More Articles for AMED

Headlines

Articles On GuruFocus.com
comment on AMED Jun 20 2012 
well undervalued, st Jan 24 2012 
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 06 2012 
AMED: Investment Opportunity When the Price Hits an 8-Year Low Dec 27 2011 
Almost Family: The Magic Formula Stock is getting cheaper and cheaper Dec 11 2011 
guru bargain Oct 05 2011 
Magic Formula Stock: Amedisys (AMED) Aug 05 2011 
Home Healthcare: Heavily Shorted long Opportunity May 30 2011 
Amedisys Inc (AMED) CFO Dale E Redman buys 1,000 Shares Aug 25 2010 
Amedisys Inc Reports Operating Results (10-Q) Aug 09 2010 

More From Other Websites
Nasdaq stocks posting largest percentage decreases Mar 27 2015
The Zacks Analyst Blog Highlights: Natus Medical, Mead Johnson Nutrition, Amedisys, Quest... Mar 23 2015
Amedisys Downgraded to Hold on Hospice Struggles - Analyst Blog Mar 11 2015
Amedisys Q4 Earnings in Line, Revenues Miss the Mark - Analyst Blog Mar 09 2015
10-K for Amedisys, Inc. Mar 06 2015
Tenet Healthcare's Business Poised for Growth - Analyst Blog Mar 05 2015
Amedisys Reports Fourth Quarter Financial Results Mar 04 2015
Amedisys Inc Earnings Call scheduled for 10:00 am ET today Mar 04 2015
AMEDISYS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Mar 04 2015
Amedisys meets 4Q profit forecasts Mar 04 2015
Amedisys meets 4Q profit forecasts Mar 04 2015
Q4 2014 Amedisys Inc Earnings Release - Before Market Open Mar 04 2015
Amedisys Reports Fourth Quarter Financial Results Mar 04 2015
Amedisys Announces Clinical Excellence in Speech Language Pathology Mar 03 2015
Amedisys Statement Regarding Inventory and Data Security Reporting Mar 03 2015
Acadia, AmSurg Lead In Outpatient Medical Group Mar 02 2015
Amsurg (AMSG) Beats Q4 Earnings, Revenues; Outlook Bright - Analyst Blog Feb 26 2015
Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date Feb 25 2015
Amedisys Announces Clinical Excellence in Speech Language Pathology Feb 25 2015
China Cord Blood Corp (CO) Jumps: Stock Up 9.5% - Tale of the Tape Feb 20 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK